176
Views
73
CrossRef citations to date
0
Altmetric
Original Research

Lactoferrin- and RGD-comodified, temozolomide and vincristine-coloaded nanostructured lipid carriers for gliomatosis cerebri combination therapy

, , , , , & show all
Pages 3039-3051 | Published online: 22 May 2018

References

  • HigaMKatagiriCShimizu-OkabeCIdentification of a novel cell-penetrating peptide targeting human glioblastoma cell lines as a cancer-homing transporterBiochem Biophys Res Commun201545720621225562654
  • HouLCVeeravaguAHsuARTseVCRecurrent glioblastoma multiforme: a review of natural history and management optionsNeurosurg Focus2006204E5
  • KimSSHarfordJBPirolloKFChangEHEffective treatment of glioblastoma requires crossing the blood-brain barrier and targeting tumors including cancer stem cells: the promise of nanomedicineBiochem Biophys Res Commun201546848548926116770
  • WuMFanYLvSXiaoBYeMZhuXVincristine and temozolomide combined chemotherapy for the treatment of glioma: a comparison of solid lipid nanoparticles and nanostructured lipid carriers for dual drugs deliveryDrug Deliv20162382720272526203691
  • SongSMaoGDuJZhuXNovel RGD containing, temozolomide-loading nanostructured lipid carriers for glioblastoma multiforme chemotherapyDrug Deliv20162341404140826203687
  • ChekhoninVPBaklaushevVPYusubalievaGMTargeted delivery of liposomal nanocontainers to the peritumoral zone of glioma by means of monoclonal antibodies against GFAP and the extracellular loop of Cx43Nanomedicine20128637021703991
  • ZhangBSunXMeiHLDLR-mediated peptide-22-conjugated nanoparticles for dual-targeting therapy of brain gliomaBiomaterials2013349171918224008043
  • GastaldiLBattagliaLPeiraESolid lipid nanoparticles as vehicles of drugs to the brain: current state of the artEur J Pharm Biopharm20148743344424833004
  • QuJZhangLChenZNanostructured lipid carriers, solid lipid nanoparticles, and polymeric nanoparticles: which kind of drug delivery system is better for glioblastoma chemotherapy?Drug Deliv20162393408341627181462
  • ChenZLaiXSongSZhuXZhuJNanostructured lipid carriers based temozolomide and gene co-encapsulated nanomedicine for gliomatosis cerebri combination therapyDrug Deliv20162341369137326017099
  • MullerRHRadtkeMWissingSASolid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparationsAdv Drug Deliv Rev200254S131S15512460720
  • SaupeAWissingSALenkASchmidtCMüllerRHSolid Lipid Nanoparticles (SLN) and Nanostructured Lipid Carriers (NLC)–structural investigations on two different carrier systemsBio-Med Mater Eng200515393402
  • KuoYCChengSJBrain targeted delivery of carmustine using solid lipid nanoparticles modified with tamoxifen and lactoferrin for antitumor proliferationInt J Pharm20164991–2101926721730
  • MiaoDJiangMLiuZCo-administration of dual-targeting nanoparticles with penetration enhancement peptide for antiglioblastoma therapyMol Pharm20141119010124295590
  • ArcellaAOlivaMAStaffieriSIn vitro and in vivo effect of human lactoferrin on glioblastoma growthJ Neurosurg201512341026103526186026
  • GaoHXiongYZhangSYangZCaoSJiangXRGD and interleukin-13 peptide functionalized nanoparticles for enhanced glioblastoma cells and neovasculature dual targeting delivery and elevated tumor penetrationMol Pharm20141131042105224521297
  • MiuraYTakenakaTTohKCyclic RGD-linked polymeric micelles for targeted delivery of platinum anticancer drugs to glioblastoma through the blood-brain tumor barrierACS Nano20137108583859224028526
  • YanJWangYJiaYCo-delivery of docetaxel and curcumin prodrug via dual-targeted nanoparticles with synergistic antitumor activity against prostate cancerBiomed Pharmacother20178837438328122302
  • WangWZhouFGeLLiuXKongFTransferrin-PEG-PE modified dexamethasone conjugated cationic lipid carrier mediated gene delivery system for tumor-targeted transfectionInt J Nanomedicine201272513252222679364
  • HuangFYChenWJLeeWYLoSTLeeTWLoJMIn vitro and in vivo evaluation of lactoferrin-conjugated liposomes as a novel carrier to improve the brain deliveryInt J Mol Sci20131422862287423434652
  • TianXHLinXNWeiFEnhanced brain targeting of temozolomide in polysorbate-80 coated polybutylcyanoacrylate nanoparticlesInt J Nanomedicine2011644545221445277
  • ChirioDGallarateMPeiraEPositive-charged solid lipid nanoparticles as paclitaxel drug delivery system in glioblastoma treatmentEur J Pharm Biopharm201488374675825445304
  • WangHAgarwalPZhaoSHyaluronic acid-decorated dual responsive nanoparticles of Pluronic F127, PLGA, and chitosan for targeted co-delivery of doxorubicin and irinotecan to eliminate cancer stem-like cellsBiomaterials201572748926344365
  • WangHSunGZhangZOuYTranscription activator, hyaluronic acid and tocopheryl succinate multi-functionalized novel lipid carriers encapsulating etoposide for lymphoma therapyBiomed Pharmacother20179124125028460227
  • ZhuBYuLYueQCo-delivery of vincristine and quercetin by nanocarriers for lymphoma combination chemotherapyBiomed Pharmacother20179128729428463792
  • ZhangRRuYGaoYLiJMaoSLayer-by-layer nanoparticles co-loading gemcitabine and platinum (IV) prodrugs for synergistic combination therapy of lung cancerDrug Des Devel Ther20171126312642
  • ZhuBZhangHYuLNovel transferrin modified and doxorubicin loaded Pluronic 85/lipid-polymeric nanoparticles for the treatment of leukemia: in vitro and in vivo therapeutic effect evaluationBiomed Pharmacother20178654755428024291
  • GaoHYangZCaoSTumor cells and neovasculature dual targeting delivery for glioblastoma treatmentBiomaterials201435374382
  • ShaoZShaoJTanBTargeted lung cancer therapy: preparation and optimization of transferrin-decorated nanostructured lipid carriers as novel nanomedicine for co-delivery of anticancer drugs and DNAInt J Nanomedicine2015101223123325709444
  • Harush-FrenkelORozenturEBenitaSAltschulerYSurface charge of nanoparticles determines their endocytic and transcytotic pathway in polarized MDCK cellsBiomacromolecules20089243544318189360
  • BoylesMSKristlTAndoschAChitosan functionalisation of gold nanoparticles encourages particle uptake and induces cytotoxicity and pro-inflammatory conditions in phagocytic cells, as well as enhancing particle interactions with serum componentsJ Nanobiotechnol20151384
  • PugliaCOffertaATirendiGGDesign of solid lipid nanoparticles for caffeine topical administrationDrug Deliv201623364024735249
  • YouPYuanRChenCDesign and evaluation of lidocaine- and prilocaine-coloaded nanoparticulate drug delivery systems for topical anesthetic analgesic therapy: a comparison between solid lipid nanoparticles and nanostructured lipid carriersDrug Des Devel Ther20171127432752
  • ChenCYouPA novel local anesthetic system: transcriptional trans-activator peptide-decorated nanocarriers for skin delivery of ropivacaineDrug Des Devel Ther20171119411949
  • LiuYGaoDZhangXAntitumor drug effect of betulinic acid mediated by polyethylene glycol modified liposomesMater Sci Eng C Mater Biol Appl20166412413227127036
  • PeetersLSandersNNJonesADemeesterJDe SmedtSCPost-pegylated lipoplexes are promising vehicles for gene delivery in RPE cellsJ Control Release2007121320821717630013
  • LiHShiLWeiJCellular uptake and anticancer activity of salvianolic acid B phospholipid complex loaded nanoparticles in head and neck cancer and precancer cellsColloids Surf B Biointerfaces2016147657227490455
  • LiSWangLLiNLiuYSuHCombination lung cancer chemotherapy: design of a pH-sensitive transferrin-PEG-Hz-lipid conjugate for the co-delivery of docetaxel and baicalinBiomed Pharmacother20179554855528869892
  • ChouTCTalalayPQuantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitorsAdv Enzyme Regul19842227556382953